Children's Hospital Research Institute of Manitoba/University of Manitoba
Winnipeg, Manitoba, R3E 3P4, Canada
Location status: Recruiting
NCT Number: NCT04621396
The overall aim of this project is to understand the independent roles of maternal factors, intrauterine exposures, genetic factors, and postnatal environment on the development of obesity and youth-onset type 2 diabetes (T2D) in childhood.
Interested in participating?
Request InfoUp to 18 year
All sexes
Observational
Winnipeg, Manitoba, R3E 3P4, Canada
Location status: Recruiting
Our primary objective for the study is to clinically and metabolically phenotype parents and their offspring to identify risk factors for obesity, T2D, and cardiometabolic risk in childhood and adolescence in a prospective birth cohort by reporting:
Secondary Objectives:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 18 years
Development of obesity defined by the International task force on obesity cut offs for age and gender.
Time frame: 18 years
Development of type 2 diabetes defined by diagnostic criteria in the Canadian Diabetes association 2008 guidelines in childhood (≤ 7 years) or adolescence (12-16 years).
Contact information is provided by the study sponsor or research team.
Brandy A Wicklow, MD, MSc
CONTACT
Elizabeth AC Sellers, MD, MSc
CONTACT
University of Manitoba
Other
Genetic and Environmental Influences on Development of Type 2 Diabetes in Childhood: The Next Generation Longitudinal Birth Cohort.
Acronym: NextGen
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00921882
Diabetes Mellitus, Diabetes Mellitus, Type 2
Sherbrooke, Quebec, Canada
View Trial DetailsNCT06457139
Diabetes Mellitus, Diabetes Mellitus, Type 2
Worcester, Massachusetts, United States
View Trial DetailsNCT06319560
Diabetes Mellitus, Diabetes Mellitus, Type 2
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT06005987
Diabetes Mellitus, Diabetes Mellitus, Type 2
Augusta, Georgia, United States
View Trial Details